Unable to view this mail? Please click here to view in browser
Vertical_Talk Healthcare Antibody Drug Conjugates
Future Pharma
Merck R&D facility
Cancer-Associated Fusion Events
e-Newsletter www.pharmafocusasia.com | Archives | Advertise

News

Drug firm Pfizer to sell Thane plant to Vidhi Research...

Drug maker Novo Nordisk to build $78 million manufacturing...

Amgen, Allergan say Avastin copycat succeeds in lung...
Press Releases

Regen Biopharma Inc. Initiates Small Molecule Hit Validation Study...

CVS/pharmacy commits to Creating Safer Communities Through...

CTI BioPharma to Present at the Ladenburg Thalmann...

Events

Sep 29th - Oct 3rd
FIP 2015

Sep 29th - Oct 1st
MAGHREB PHARMA Expo 2015

Sep 29th - Oct 1st
Global Drug Formulations Summit 2015

Articles  
Antibody Drug Conjugates in Reducing Disease Burden

Antibody Drug Conjugates provide a high level of promise, and hence there will be a conscious effort to expand the application(s) of this technology to disease indications beyond oncology provide a high level of promise, and hence there will be a conscious effort to expand the application of this technology to disease indications beyond oncology....
Future Pharma
Pharmaceuticals play a critical role in improving human and animal health and well-being. They bring tremendous benefits to public health and economic productivity by saving lives, increasing life spans, reducing suffering, preventing surgeries, and even reducing hospital stays...
Projects  
Merck Serono to invest 65 million for Biopharmaceutical R&D facility expansion in Germany
Merck Serono, the biopharmaceutical business of Merck, announced the expansion of its R&D facility in Darmstadt, Germany with an investment of 65 million.Merck is investing 65 million in a new laboratory building that will span more than 16,000 square meters and accommodate...
Research Insights  
FARE-CAFE: a database of functional and regulatory elements of cancer-associated fusion events
Chromosomal translocation (CT) is of enormous clinical interest because this disorder is associated with various major solid tumors and leukemia. A tumor-specific fusion gene event may occur when a translocation joins two separate genes. Currently, various CT databases provide...
Current Issue
Current Issue
Editorial Calender
Media Pack
Books
e-Magazine| Subscribe | Unsubscribe Pharma Focus Asia
www.pharmafocusasia.com – a product of Ochre Media Pvt. Ltd.
Ochre Media Pvt Ltd. Media Resource Centre, 2nd Floor, Oxford Plaza, Secunderabad - 500 003, Telangana, India
Tel: +91 40 4961 4567 | Fax: +91 40 4961 4555